The global microfluidic devices market is expected to gain impetus from increasing technological advancements in the biotechnology domain. According to a report by Fortune Business Insights, titled, “Microfluidic Devices Market Size, Share & Industry Analysis, By Device Type (Chips, Sensors, and Others), By Material (Glass, Silicon, PDMS and Others), By Applications (Pharmaceutical & Life Science Research, Diagnosis & Treatment, and Others), By End-user (Diagnostic Centers, Research Institutes, Pharmaceutical and Biotechnology Companies, Healthcare Facilities and Others) and Regional Forecast, 2019-2026,”.
the market is projected to reach USD 22.65 Billion by 2026, thereby exhibiting a CAGR of 20.5% during the forecast period. However, the global microfluidic devices market size was valued at USD 5.14 Billion in 2018. The report further states that renowned market players are focusing on low-cost materials for manufacturing microfluidic sensors and chips. It would contribute to the market growth in the forthcoming years.
Microfluidic Devices Market Segmentation
By Device Type
- Pharmaceutical & Life Science Research
- Diagnosis & Treatment
By End User
- Pharmaceutical and Biotechnology Companies
- Research Institutes
- Diagnostic Centers
- Healthcare Facilities and Others
- North America (U.S. and Canada)
- Europe (U.K., Germany, France, Italy, Spain, Scandinavia, and Rest of Europe)
- Asia Pacific (Japan, China, India, Australia, Southeast Asia, and Rest of Asia Pacific)
- Latin America (Brazil, Mexico, and Rest of Latin America)
Middle East & Africa (South Africa, GCC and Rest of Middle East & Africa)
Fluidigm Corporation Unveils its Automated RNA Sequencing Library Preparation Workflow
Fluidigm Corporation, a designer, manufacturer, and seller of biological research equipment, headquartered in the U.S., announced the launch of its automated RNA sequencing (RNA-seq) library preparation workflow in August 2019. It is developed for the company’s Juno microfluidic system. It will aid in reducing the hands-on time as well as cost per sample by up to 50% for the molecular laboratory. It will also provide flexible scalability and greater efficiency. It is best suited for commercial service providers, core facilities, and sequencing centers.
Fortune Business Insights offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.
Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.